{"entity":{"type":"insider","cik":"0001283569","url":"/insider/0001283569","json_url":"/insider/0001283569.json","name":"MUEHL DANIEL W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":59,"n_filings":35,"first":"2018-12-06","last":"2022-11-03","span_basis":"filed_date"},"name_variants":[{"name":"MUEHL DANIEL W","source":"filing","n_filings":35,"first_seen":"2018-12-06","last_seen":"2022-11-03"}],"transactions":[{"id":6118017,"accession":"0000899243-22-034892","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-034892","line_url":"/filing/0000899243-22-034892#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2513.0,"shares_display":"2,513","price_per_share":0.983,"price_display":"0.98","price_state":"stated","total_value":2470.279,"total_display":"2,470.28","shares_owned_after":102271.0,"shares_owned_after_display":"102,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider"},{"id":6118014,"accession":"0000899243-22-034892","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-034892","line_url":"/filing/0000899243-22-034892#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2066.0,"shares_display":"2,066","price_per_share":0.983,"price_display":"0.98","price_state":"stated","total_value":2030.878,"total_display":"2,030.88","shares_owned_after":104830.0,"shares_owned_after_display":"104,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider"},{"id":6443901,"accession":"0000899243-22-030417","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030417","line_url":"/filing/0000899243-22-030417#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2234.0,"shares_display":"2,234","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":2680.8,"total_display":"2,680.80","shares_owned_after":99161.0,"shares_owned_after_display":"99,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6588708,"accession":"0000899243-22-027578","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-027578","line_url":"/filing/0000899243-22-027578#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2554.0,"shares_display":"2,554","price_per_share":1.4609,"price_display":"1.46","price_state":"stated","total_value":3731.1386,"total_display":"3,731.14","shares_owned_after":93807.0,"shares_owned_after_display":"93,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider"},{"id":6588705,"accession":"0000899243-22-027578","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-027578","line_url":"/filing/0000899243-22-027578#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":1.4609,"price_display":"1.46","price_state":"stated","total_value":3067.89,"total_display":"3,067.89","shares_owned_after":96332.0,"shares_owned_after_display":"96,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider"},{"id":6803851,"accession":"0000899243-22-020947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020947","line_url":"/filing/0000899243-22-020947#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2327.0,"shares_display":"2,327","price_per_share":0.6424,"price_display":"0.64","price_state":"stated","total_value":1494.8648,"total_display":"1,494.86","shares_owned_after":90737.0,"shares_owned_after_display":"90,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6713962,"accession":"0000899243-22-016299","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016299","line_url":"/filing/0000899243-22-016299#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2508.0,"shares_display":"2,508","price_per_share":1.9698,"price_display":"1.97","price_state":"stated","total_value":4940.2584,"total_display":"4,940.26","shares_owned_after":85439.0,"shares_owned_after_display":"85,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":6713959,"accession":"0000899243-22-016299","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-016299","line_url":"/filing/0000899243-22-016299#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":1.9698,"price_display":"1.97","price_state":"stated","total_value":4061.7276,"total_display":"4,061.73","shares_owned_after":88002.0,"shares_owned_after_display":"88,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":6139235,"accession":"0000899243-22-009064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-009064","line_url":"/filing/0000899243-22-009064#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10416.0,"shares_display":"10,416","price_per_share":1.866,"price_display":"1.87","price_state":"stated","total_value":19436.256,"total_display":"19,436.26","shares_owned_after":82324.0,"shares_owned_after_display":"82,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider"},{"id":6139233,"accession":"0000899243-22-009064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-009064","line_url":"/filing/0000899243-22-009064#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":290.0,"shares_display":"290","price_per_share":1.866,"price_display":"1.87","price_state":"stated","total_value":541.14,"total_display":"541.14","shares_owned_after":72490.0,"shares_owned_after_display":"72,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider"},{"id":6087663,"accession":"0000899243-22-004568","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-004568","line_url":"/filing/0000899243-22-004568#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2983.0,"shares_display":"2,983","price_per_share":1.9397,"price_display":"1.94","price_state":"stated","total_value":5786.1251,"total_display":"5,786.13","shares_owned_after":70045.0,"shares_owned_after_display":"70,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider"},{"id":6087657,"accession":"0000899243-22-004568","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-004568","line_url":"/filing/0000899243-22-004568#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2453.0,"shares_display":"2,453","price_per_share":1.9396,"price_display":"1.94","price_state":"stated","total_value":4757.8388,"total_display":"4,757.84","shares_owned_after":72217.0,"shares_owned_after_display":"72,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider"},{"id":5194982,"accession":"0000899243-21-046771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046771","line_url":"/filing/0000899243-21-046771#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":248.0,"shares_display":"248","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":744.0,"total_display":"744.00","shares_owned_after":67403.0,"shares_owned_after_display":"67,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-03","scope":"insider"},{"id":5194850,"accession":"0000899243-21-042703","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-042703","line_url":"/filing/0000899243-21-042703#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2482.0,"shares_display":"2,482","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":11293.1,"total_display":"11,293.10","shares_owned_after":64505.0,"shares_owned_after_display":"64,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":5194844,"accession":"0000899243-21-042703","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-042703","line_url":"/filing/0000899243-21-042703#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2041.0,"shares_display":"2,041","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":9286.55,"total_display":"9,286.55","shares_owned_after":67089.0,"shares_owned_after_display":"67,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":5038231,"accession":"0000899243-21-035117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-035117","line_url":"/filing/0000899243-21-035117#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":1217.61,"total_display":"1,217.61","shares_owned_after":61364.0,"shares_owned_after_display":"61,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":4974976,"accession":"0000899243-21-031443","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-031443","line_url":"/filing/0000899243-21-031443#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2473.0,"shares_display":"2,473","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":11919.86,"total_display":"11,919.86","shares_owned_after":58459.0,"shares_owned_after_display":"58,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider"},{"id":4974972,"accession":"0000899243-21-031443","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-031443","line_url":"/filing/0000899243-21-031443#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2034.0,"shares_display":"2,034","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":9803.88,"total_display":"9,803.88","shares_owned_after":61050.0,"shares_owned_after_display":"61,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider"},{"id":4550983,"accession":"0000899243-21-021858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-021858","line_url":"/filing/0000899243-21-021858#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231.0,"shares_display":"231","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":1300.53,"total_display":"1,300.53","shares_owned_after":55308.0,"shares_owned_after_display":"55,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-03","scope":"insider"},{"id":5187924,"accession":"0000899243-21-018278","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-018278","line_url":"/filing/0000899243-21-018278#line-6","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2183.0,"shares_display":"2,183","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":12093.82,"total_display":"12,093.82","shares_owned_after":52008.0,"shares_owned_after_display":"52,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider"},{"id":5187916,"accession":"0000899243-21-018278","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-018278","line_url":"/filing/0000899243-21-018278#line-5","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1448.0,"shares_display":"1,448","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":8021.92,"total_display":"8,021.92","shares_owned_after":54977.0,"shares_owned_after_display":"54,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider"},{"id":5187914,"accession":"0000899243-21-018278","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-018278","line_url":"/filing/0000899243-21-018278#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1206.0,"shares_display":"1,206","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":6681.24,"total_display":"6,681.24","shares_owned_after":53358.0,"shares_owned_after_display":"53,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider"},{"id":5454978,"accession":"0000899243-21-009505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-009505","line_url":"/filing/0000899243-21-009505#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":1566.21,"total_display":"1,566.21","shares_owned_after":47566.0,"shares_owned_after_display":"47,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5454975,"accession":"0000899243-21-009505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-009505","line_url":"/filing/0000899243-21-009505#line-1","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":1302.03,"total_display":"1,302.03","shares_owned_after":47252.0,"shares_owned_after_display":"47,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5087538,"accession":"0000899243-21-004676","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-004676","line_url":"/filing/0000899243-21-004676#line-6","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9254.0,"shares_display":"9,254","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":73754.38,"total_display":"73,754.38","shares_owned_after":46990.0,"shares_owned_after_display":"46,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5087537,"accession":"0000899243-21-004676","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-004676","line_url":"/filing/0000899243-21-004676#line-5","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1431.0,"shares_display":"1,431","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":11405.07,"total_display":"11,405.07","shares_owned_after":36374.0,"shares_owned_after_display":"36,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5087536,"accession":"0000899243-21-004676","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-004676","line_url":"/filing/0000899243-21-004676#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1187.0,"shares_display":"1,187","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":9460.39,"total_display":"9,460.39","shares_owned_after":37744.0,"shares_owned_after_display":"37,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":3240123,"accession":"0000899243-20-032934","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-032934","line_url":"/filing/0000899243-20-032934#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":1217.61,"total_display":"1,217.61","shares_owned_after":34737.0,"shares_owned_after_display":"34,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider"},{"id":3240119,"accession":"0000899243-20-032934","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-032934","line_url":"/filing/0000899243-20-032934#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208.0,"shares_display":"208","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":1017.12,"total_display":"1,017.12","shares_owned_after":34424.0,"shares_owned_after_display":"34,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider"},{"id":2785169,"accession":"0000899243-20-030470","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030470","line_url":"/filing/0000899243-20-030470#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1382.0,"shares_display":"1,382","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":6813.26,"total_display":"6,813.26","shares_owned_after":34163.0,"shares_owned_after_display":"34,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":2785165,"accession":"0000899243-20-030470","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-030470","line_url":"/filing/0000899243-20-030470#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1152.0,"shares_display":"1,152","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":5679.36,"total_display":"5,679.36","shares_owned_after":32478.0,"shares_owned_after_display":"32,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":2895725,"accession":"0000899243-20-024507","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-024507","line_url":"/filing/0000899243-20-024507#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":237.0,"shares_display":"237","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":1256.1,"total_display":"1,256.10","shares_owned_after":31074.0,"shares_owned_after_display":"31,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-08","scope":"insider"},{"id":2895717,"accession":"0000899243-20-024507","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-024507","line_url":"/filing/0000899243-20-024507#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":1049.4,"total_display":"1,049.40","shares_owned_after":30748.0,"shares_owned_after_display":"30,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-08","scope":"insider"},{"id":2287824,"accession":"0000899243-20-023501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-023501","line_url":"/filing/0000899243-20-023501#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242.0,"shares_display":"242","price_per_share":5.07,"price_display":"5.07","price_state":"stated","total_value":1226.94,"total_display":"1,226.94","shares_owned_after":30477.0,"shares_owned_after_display":"30,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-08-27","scope":"insider"},{"id":2778887,"accession":"0000899243-20-021479","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-021479","line_url":"/filing/0000899243-20-021479#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1367.0,"shares_display":"1,367","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":8092.64,"total_display":"8,092.64","shares_owned_after":30172.0,"shares_owned_after_display":"30,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2778882,"accession":"0000899243-20-021479","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-021479","line_url":"/filing/0000899243-20-021479#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1139.0,"shares_display":"1,139","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":6742.88,"total_display":"6,742.88","shares_owned_after":28471.0,"shares_owned_after_display":"28,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2057628,"accession":"0000899243-20-015481","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015481","line_url":"/filing/0000899243-20-015481#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":256.0,"shares_display":"256","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":1799.68,"total_display":"1,799.68","shares_owned_after":27054.0,"shares_owned_after_display":"27,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":2057625,"accession":"0000899243-20-015481","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-015481","line_url":"/filing/0000899243-20-015481#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214.0,"shares_display":"214","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":1504.42,"total_display":"1,504.42","shares_owned_after":26748.0,"shares_owned_after_display":"26,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":3276285,"accession":"0000899243-20-014453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014453","line_url":"/filing/0000899243-20-014453#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":247.0,"shares_display":"247","price_per_share":6.91,"price_display":"6.91","price_state":"stated","total_value":1706.77,"total_display":"1,706.77","shares_owned_after":26494.0,"shares_owned_after_display":"26,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-27","filed_date":"2020-05-28","scope":"insider"},{"id":2132683,"accession":"0000899243-20-012238","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-012238","line_url":"/filing/0000899243-20-012238#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":9776.7,"total_display":"9,776.70","shares_owned_after":26194.0,"shares_owned_after_display":"26,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2132680,"accession":"0000899243-20-012238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-012238","line_url":"/filing/0000899243-20-012238#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1006.0,"shares_display":"1,006","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":8148.6,"total_display":"8,148.60","shares_owned_after":24334.0,"shares_owned_after_display":"24,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2455459,"accession":"0000899243-20-007186","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-007186","line_url":"/filing/0000899243-20-007186#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":259.0,"shares_display":"259","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":1864.8,"total_display":"1,864.80","shares_owned_after":22784.0,"shares_owned_after_display":"22,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":2455442,"accession":"0000899243-20-007186","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-007186","line_url":"/filing/0000899243-20-007186#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":216.0,"shares_display":"216","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":1555.2,"total_display":"1,555.20","shares_owned_after":22480.0,"shares_owned_after_display":"22,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":2039565,"accession":"0000899243-20-006483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006483","line_url":"/filing/0000899243-20-006483#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":279.0,"shares_display":"279","price_per_share":6.9,"price_display":"6.90","price_state":"stated","total_value":1925.1,"total_display":"1,925.10","shares_owned_after":22227.0,"shares_owned_after_display":"22,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-03-02","scope":"insider"},{"id":2677291,"accession":"0000899243-20-003484","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-003484","line_url":"/filing/0000899243-20-003484#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5429.0,"shares_display":"5,429","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":45657.89,"total_display":"45,657.89","shares_owned_after":21959.0,"shares_owned_after_display":"21,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":2677268,"accession":"0000899243-20-003484","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-003484","line_url":"/filing/0000899243-20-003484#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5043.0,"shares_display":"5,043","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":42411.63,"total_display":"42,411.63","shares_owned_after":15117.0,"shares_owned_after_display":"15,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":8545155,"accession":"0000899243-19-028564","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028564","line_url":"/filing/0000899243-19-028564#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254.0,"shares_display":"254","price_per_share":14.59,"price_display":"14.59","price_state":"stated","total_value":3705.86,"total_display":"3,705.86","shares_owned_after":9934.0,"shares_owned_after_display":"9,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider"},{"id":8545152,"accession":"0000899243-19-028564","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-028564","line_url":"/filing/0000899243-19-028564#line-3","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":212.0,"shares_display":"212","price_per_share":14.59,"price_display":"14.59","price_state":"stated","total_value":3093.08,"total_display":"3,093.08","shares_owned_after":9626.0,"shares_owned_after_display":"9,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider"},{"id":8050699,"accession":"0000899243-19-028299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028299","line_url":"/filing/0000899243-19-028299#line-2","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242.0,"shares_display":"242","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":2468.4,"total_display":"2,468.40","shares_owned_after":9369.0,"shares_owned_after_display":"9,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-29","scope":"insider"},{"id":8437879,"accession":"0000899243-19-023016","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-023016","line_url":"/filing/0000899243-19-023016#line-4","is_derivative":false,"issuer_cik":"0001283569","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001283569","owner_cik":"0001283569","owner_name":"MUEHL DANIEL W","owner_url":"/insider/0001283569","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":270.0,"shares_display":"270","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":1406.7,"total_display":"1,406.70","shares_owned_after":9065.0,"shares_owned_after_display":"9,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider"}],"next_cursor":"2019-09-04|8437879","ledger_fault":false,"count":{"value":59,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":59,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":59},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":35,"first_seen":"2018-12-06","last_seen":"2022-11-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283569","retrieved_at":"2026-08-21T19:10:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}